180 results on '"Poluzzi, Elisabetta"'
Search Results
2. Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
3. Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
4. Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
5. The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
6. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
7. Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
8. Ethical Review of In Silico Methodologies
9. Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach
10. Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System
11. Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
12. Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”
13. Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants
14. Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
15. ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance
16. Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective.
17. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems.
18. Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems
19. Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System
20. The prevalence of polypharmacy in older Europeans: A multi‐national database study of general practitioner prescribing.
21. Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE’s key recommendations
22. The evolving role of disproportionality analysis in pharmacovigilance
23. A collection of Predicted No-Effect Concentrations of human pharmaceuticals and their metabolites
24. Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
25. The Prevalence of Polypharmacy In Older Europeans: A Multi-country Database Study of General Practitioner Prescribing
26. Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System
27. Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward.
28. Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
29. Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
30. Standardization of drug names in the FDA Adverse Event Reporting System: The DiAna dictionary
31. Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice
32. The environmental impact of pharmaceuticals in Italy : Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies
33. The environmental impact of pharmaceuticals in Italy: integrating healthcare and eco‐toxicological data to assess and potentially mitigate their diffusion to water supplies
34. Estimating the environmental impact of antibiotics through drug utilisation and eco-toxicological data: The italian context
35. Impact of regulatory restrictions on the use of valproic acid in women of childbearing age: An Italian study
36. Il ruolo dei Comitati Etici in Italia: ambiti di competenza e impatto del Regolamento Europeo 536/14
37. Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective
38. Exploring the underlying mechanisms of drug‐induced impulse control disorders: a pharmacovigilance‐pharmacodynamic study
39. QT prolongation with anticancer drugs: a multimodal issue
40. Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct
41. PSAT122 The Changing Face of Drug-Induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System
42. The COVID-19 Adversome
43. Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies
44. Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System
45. Identifying medications underlying communication atypicalities in psychotic and affective disorders: A pharmacovigilance study within the FDA Adverse Event Reporting System
46. Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People
47. Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation
48. Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study
49. The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System
50. Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.